Yeh Y.-T.YEN-WEN WU2021-03-182021-03-1820160914-5087https://scholars.lib.ntu.edu.tw/handle/123456789/553716[SDGs]SDG3biguanide; insulin; oral antidiabetic agent; antidiabetic agent; insulin; atherosclerosis; diabetes mellitus; diabetic patient; disease duration; glycemic control; heart disease; heart infarction; human; in-stent restenosis; insulin treatment; Letter; percutaneous coronary intervention; peripheral occlusive artery disease; diabetes mellitus; transluminal coronary angioplasty; treatment outcome; Angioplasty, Balloon, Coronary; Diabetes Mellitus; Humans; Hypoglycemic Agents; Insulin; Percutaneous Coronary Intervention; Treatment Outcomeletter10.1016/j.jjcc.2015.07.011269260122-s2.0-84959161430